Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer

NCT05412758 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05412758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05412758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Recruiting
Start date
February 28, 2022
Completion date
October 31, 2025
Enrollment
648 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breath analysis, gastric cancer, metabonomics/lipidomics, microbioata, microbiome, microbiome analysis, oesophageal cancer, transcriptomics, volatalomics, volatile organic compounds